4 Recruiting Studies Using Nogapendekin Alfa
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Nogapendekin Alfa
🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Advanced Lung Non-Small Cell Carcinoma
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Colorectal Carcinoma
View Study & Checklist ➔ 🟢 Recruiting Early Phase1 💊 Investigational Drug / Biologic
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
📍 Northwestern University — Chicago, Illinois
Myxoid Liposarcoma
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
📍 Washington University School of Medicine — St Louis, Missouri
Non-small Cell Lung Cancer Stage IV
View Study & Checklist ➔